OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1in Journal of Immunology Nantes, France – April 2, 2024 – 7:30 am CET – OSE.
This is a translation into English of the Universal Registration Document of the Company issued in French and it is available on the website of the Issuer OSE.